These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7913781)

  • 1. Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Kenny BA; Naylor AM; Carter AJ; Read AM; Greengrass PM; Wyllie MG
    Urology; 1994 Jul; 44(1):52-7. PubMed ID: 7913781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
    Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
    Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
    Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
    J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
    Brune ME; Katwala SP; Milicic I; Witte DG; Kerwin JF; Meyer MD; Hancock AA; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):487-94. PubMed ID: 11805208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.
    Sudoh K; Tanaka H; Inagaki O; Asano M; Takenaka T
    J Auton Pharmacol; 1996 Jun; 16(3):147-54. PubMed ID: 8884461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.
    Yamaguchi T; Nagano M; Osada Y
    J Smooth Muscle Res; 2005 Oct; 41(5):247-56. PubMed ID: 16428864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.
    Teng CM; Guh JH; Ko FN
    Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate.
    Michel MC; Grübbel B; Taguchi K; Verfürth F; Otto T; Kröpfl D
    J Auton Pharmacol; 1996 Feb; 16(1):21-8. PubMed ID: 8736427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs.
    Brune ME; Katwala SP; Milicic I; Buckner SA; Ireland LM; Kerwin JF; Hancock AA
    Pharmacology; 1996 Dec; 53(6):356-68. PubMed ID: 9032800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
    Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
    Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.
    Kenny BA; Chalmers DH; Philpott PC; Naylor AM
    Br J Pharmacol; 1995 Jul; 115(6):981-6. PubMed ID: 7582530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic alpha 1-adrenoceptors and uroselectivity.
    Andersson KE; Lepor H; Wyllie MG
    Prostate; 1997 Feb; 30(3):202-15. PubMed ID: 9122046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
    Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
    Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of alpha 1-adrenoceptor subtype mediating regulation of arterial pressure and urethral perfusion pressure in the anaesthetized rat.
    Guilmard C; Auguet M; Chabrier PE
    J Auton Pharmacol; 1996 Aug; 16(4):197-203. PubMed ID: 8953374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.